Meiji (OTCMKTS:MEJHY) is the American depositary receipt that represents shares of Meiji Holdings Co., Ltd., a Tokyo-based diversified food and pharmaceutical company. Through its two main subsidiaries, Meiji Co., Ltd. and Meiji Seika Pharma Co., Ltd., the company engages in the development, production and sale of a wide range of food and health care products.
In its food business, Meiji offers dairy products such as milk, yogurt, cheese and infant formula under the Meiji brand. The company is also known for its confectionery line, which includes chocolate, candy, gum and biscuits, marketed both domestically in Japan and across Asia. Innovative snack products such as biscuit sticks and coated snacks have helped Meiji maintain a strong presence in the competitive confectionery market.
On the pharmaceutical side, Meiji Seika Pharma focuses on prescription pharmaceuticals, vaccines and over-the-counter products. Its portfolio includes anti-infectives, central nervous system treatments and vaccines for both human and veterinary use. The company conducts research and development activities in Japan and collaborates with international partners to advance drug discovery and vaccine development.
Founded through the 2009 integration of Meiji Dairies Corporation (est. 1917) and Meiji Seika Kaisha (est. 1916), Meiji Holdings has since expanded its operations into North America, Europe and other parts of Asia. Headquartered in Tokyo, the company is led by Chairman Tsunao Kita and President Koji Yanase, who oversee a global workforce dedicated to nutrition and health care innovation.
AI Generated. May Contain Errors.
